ITOS
Price
$10.21
Change
-$0.01 (-0.10%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
391.54M
28 days until earnings call
NVAX
Price
$7.05
Change
+$0.01 (+0.14%)
Updated
Jul 10, 12:59 PM (EDT)
Capitalization
1.14B
27 days until earnings call
Interact to see
Advertisement

ITOS vs NVAX

Header iconITOS vs NVAX Comparison
Open Charts ITOS vs NVAXBanner chart's image
iTeos Therapeutics
Price$10.21
Change-$0.01 (-0.10%)
Volume$14.33K
Capitalization391.54M
Novavax
Price$7.05
Change+$0.01 (+0.14%)
Volume$1.5K
Capitalization1.14B
ITOS vs NVAX Comparison Chart in %
Loading...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITOS vs. NVAX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITOS is a StrongBuy and NVAX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (ITOS: $10.23 vs. NVAX: $7.04)
Brand notoriety: ITOS: Not notable vs. NVAX: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITOS: 37% vs. NVAX: 49%
Market capitalization -- ITOS: $391.54M vs. NVAX: $1.14B
ITOS [@Biotechnology] is valued at $391.54M. NVAX’s [@Biotechnology] market capitalization is $1.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITOS’s FA Score shows that 1 FA rating(s) are green whileNVAX’s FA Score has 0 green FA rating(s).

  • ITOS’s FA Score: 1 green, 4 red.
  • NVAX’s FA Score: 0 green, 5 red.
According to our system of comparison, ITOS is a better buy in the long-term than NVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITOS’s TA Score shows that 4 TA indicator(s) are bullish while NVAX’s TA Score has 4 bullish TA indicator(s).

  • ITOS’s TA Score: 4 bullish, 5 bearish.
  • NVAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ITOS and NVAX are a bad buy in the short-term.

Price Growth

ITOS (@Biotechnology) experienced а +0.69% price change this week, while NVAX (@Biotechnology) price change was +4.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

ITOS is expected to report earnings on Nov 05, 2025.

NVAX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVAX($1.14B) has a higher market cap than ITOS($392M). ITOS YTD gains are higher at: 33.203 vs. NVAX (-12.438). NVAX has higher annual earnings (EBITDA): 555M vs. ITOS (-146.71M). NVAX has more cash in the bank: 731M vs. ITOS (520M). ITOS has less debt than NVAX: ITOS (5.05M) vs NVAX (229M). NVAX has higher revenues than ITOS: NVAX (1.22B) vs ITOS (35M).
ITOSNVAXITOS / NVAX
Capitalization392M1.14B34%
EBITDA-146.71M555M-26%
Gain YTD33.203-12.438-267%
P/E RatioN/A2.56-
Revenue35M1.22B3%
Total Cash520M731M71%
Total Debt5.05M229M2%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ITOSNVAX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
81%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSCGX17.880.10
+0.56%
Thrivent Small Cap Growth S
TIIRX27.44N/A
N/A
Nuveen Core Equity A
SRIGX13.67N/A
N/A
Gabelli SRI AAA
DSCLX17.42N/A
N/A
DFA International Social Cor Eq Instl
AUIZX34.47N/A
N/A
AB Equity Income Z

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
+1.09%
BMRN - ITOS
50%
Loosely correlated
+2.90%
IMNM - ITOS
44%
Loosely correlated
+3.98%
IBO - ITOS
44%
Loosely correlated
+0.18%
BDTX - ITOS
44%
Loosely correlated
+5.60%
RCUS - ITOS
42%
Loosely correlated
+9.76%
More